{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:09:14Z","timestamp":1791425354350,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.bcp.2005.12.007","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T14:54:33Z","timestamp":1138373673000},"page":"882-890","source":"Crossref","is-referenced-by-count":21,"title":["The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"71","author":[{"given":"Kourosh","family":"Lotfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fyrberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Juliusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viggo","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freidoun","family":"Albertioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2005.12.007_bib1","first-page":"28","article-title":"Fludarabine phosphate: a new active agent in hematologic malignancies","volume":"31","author":"Keating","year":"1994","journal-title":"Semin Hematol"},{"issue":"5","key":"10.1016\/j.bcp.2005.12.007_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.2003.04336.x","article-title":"Mechanism of action of purine analogues in chronic lymphocytic leukaemia","volume":"121","author":"Pettitt","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bcp.2005.12.007_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/10428190290012029","article-title":"The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials","volume":"43","author":"Robak","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.bcp.2005.12.007_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.0007-1048.2001.03296.x","article-title":"Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients","volume":"116","author":"Karlsson","year":"2002","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bcp.2005.12.007_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0163-7258(91)90057-S","article-title":"Metabolism and action of purine nucleoside analogs","volume":"49","author":"Plunkett","year":"1991","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bcp.2005.12.007_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/mol.53.2.270","article-title":"Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs","volume":"53","author":"Sjoberg","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0006-2952(02)01557-5","article-title":"Selective activation of deoxycytidine kinase by thymidine-5\u2032-thiosulphate and release by deoxycytidine in human lymphocytes","volume":"65","author":"Keszler","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2005.12.007_bib8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bcp.2003.10.019","article-title":"Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining","volume":"67","author":"Keszler","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.bcp.2005.12.007_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0006-2952(98)00108-7","article-title":"Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2\u2032-deoxyadenosine (cladribine) in human lymphocytes","volume":"56","author":"Sasvari-Szekely","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2005.12.007_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/978-1-4615-5381-6_124","article-title":"Activation of deoxycytidine kinase by various nucleoside analogues","volume":"431","author":"Spasokoukotskaja","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1016\/j.bcp.2005.12.007_bib11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0006-2952(98)00150-6","article-title":"Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase","volume":"56","author":"Zhu","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2005.12.007_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0006-291X(02)00415-1","article-title":"Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-d-arabinofuranosylguanine cytotoxicity","volume":"293","author":"Lotfi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"10.1016\/j.bcp.2005.12.007_bib13","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1002\/1522-2683(200110)22:18<4016::AID-ELPS4016>3.0.CO;2-9","article-title":"Semiquantitative reverse transcription-polymerase chain reaction with the Agilent 2100 Bioanalyzer","volume":"22","author":"Gottwald","year":"2001","journal-title":"Electrophoresis"},{"issue":"3","key":"10.1016\/j.bcp.2005.12.007_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.leu.2402388","article-title":"Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5\u2032-nucleotidase mRNA measurement in cell lines and in patients with leukemia","volume":"16","author":"Mansson","year":"2002","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V96.4.1517","article-title":"High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia","volume":"96","author":"Veuger","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1098-2264(199912)26:4<355::AID-GCC10>3.0.CO;2-3","article-title":"Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL\u2013AML1 fusion transcript","volume":"26","author":"Pallisgaard","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2005.12.007_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.leu.2402752","article-title":"A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211","volume":"17","author":"Byrd","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bcp.2005.12.007_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/oxfordjournals.annonc.a058693","article-title":"High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias","volume":"5","author":"Betticher","year":"1994","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.bcp.2005.12.007_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199210083271504","article-title":"Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine","volume":"327","author":"Juliusson","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oxfordjournals.annonc.a010604","article-title":"Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia","volume":"7","author":"Juliusson","year":"1996","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.bcp.2005.12.007_bib21","first-page":"5956","article-title":"Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line","volume":"59","author":"Mansson","year":"1999","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.bcp.2005.12.007_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-2952(02)01484-3","article-title":"Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance","volume":"65","author":"Mansson","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2005.12.007_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2141.2001.02751.x","article-title":"Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide","volume":"113","author":"Lotfi","year":"2001","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib24","first-page":"391","article-title":"2\u2032-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2\u2032-deoxyadenosine resistance in lymphoid cell lines","volume":"1","author":"Orr","year":"1995","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.bcp.2005.12.007_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.1999.01509.x","article-title":"Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562","volume":"106","author":"Dumontet","year":"1999","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.bcp.2005.12.007_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004320050185","article-title":"Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-d-arabinofuranosyl-2-fluoroadenine","volume":"124","author":"Bai","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"10.1016\/j.bcp.2005.12.007_bib27","first-page":"2343","article-title":"Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity","volume":"56","author":"Hapke","year":"1996","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bcp.2005.12.007_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.1974.tb06772.x","article-title":"Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside","volume":"27","author":"Tattersall","year":"1974","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bcp.2005.12.007_bib29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.V81.3.597.597","article-title":"Relationship of deoxycytidine kinase and cytoplasmic 5\u2032-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine","volume":"81","author":"Kawasaki","year":"1993","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2141.1994.tb06728.x","article-title":"Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients","volume":"87","author":"Arner","year":"1994","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.bcp.2005.12.007_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00001813-199706000-00015","article-title":"Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia","volume":"8","author":"Stammler","year":"1997","journal-title":"Anticancer Drugs"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2005.12.007_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10428199809059234","article-title":"Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia","volume":"31","author":"Kakihara","year":"1998","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.bcp.2005.12.007_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2141.2003.04386.x","article-title":"Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine","volume":"122","author":"Galmarini","year":"2003","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.bcp.2005.12.007_bib34","first-page":"2719","article-title":"Phase II trial of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5\u2032-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity","volume":"47","author":"Leiby","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2005.12.007_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/978-1-4615-5381-6_134","article-title":"Relationship between cladribine (CdA) plasma, intracellular CdA-5\u2032-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL)","volume":"431","author":"Albertioni","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.bcp.2005.12.007_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-0609.2002.02785.x","article-title":"Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia","volume":"69","author":"Veuger","year":"2002","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.bcp.2005.12.007_bib37","first-page":"617","article-title":"5-(3)-Nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine","volume":"89","author":"Galmarini","year":"2004","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bcp.2005.12.007_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2004-03-1046","article-title":"Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations","volume":"105","author":"Mackey","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2005.12.007_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2004.04.016","article-title":"Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity","volume":"213","author":"Sigmond","year":"2004","journal-title":"Cancer Lett"},{"issue":"9","key":"10.1016\/j.bcp.2005.12.007_bib40","first-page":"2389","article-title":"Resistance to 1-beta-d-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene","volume":"52","author":"Owens","year":"1992","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.bcp.2005.12.007_bib41","first-page":"780","article-title":"Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside","volume":"8","author":"Flasshove","year":"1994","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bcp.2005.12.007_bib42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.leu.2402112","article-title":"Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and\/or refractory acute myeloid leukemia (AML)","volume":"15","author":"van den Heuvel-Eibrink","year":"2001","journal-title":"Leukemia"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2005.12.007_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/10428199509059642","article-title":"Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy","volume":"18","author":"Gruber","year":"1995","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib44","first-page":"705","article-title":"Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa","volume":"18","author":"Miyamoto","year":"2001","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.bcp.2005.12.007_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.yexcr.2004.03.028","article-title":"Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts","volume":"297","author":"Swiggers","year":"2004","journal-title":"Exp Cell Res"},{"issue":"12","key":"10.1016\/j.bcp.2005.12.007_bib46","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0006-2952(03)00182-5","article-title":"Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes","volume":"65","author":"Csapo","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2005.12.007_bib47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-2952(02)01559-9","article-title":"Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes","volume":"65","author":"Van Den Neste","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2005.12.007_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcp.2004.02.031","article-title":"Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells","volume":"68","author":"Smal","year":"2004","journal-title":"Biochem Pharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205008142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205008142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T10:44:19Z","timestamp":1586688259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295205008142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0006295205008142"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2005.12.007","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}